Lufax Holding Ltd vs Sana Biotechnology Inc — how do they compare? Lufax Holding Ltd trades at $1.4 (market cap $2.41B), while Sana Biotechnology Inc trades at $3.17 (market cap $873.84M). The key difference: Lufax Holding Ltd is far larger — about 2.8× Sana Biotechnology Inc's market cap. Which is the better fit depends on your goals.
| LU | SANA | |
|---|---|---|
Market Cap | $2.41B | $873.84M |
Sector | Technology | Health |
52-Week High | $4.40 | $5.92 |
52-Week Low | $1.23 | $2.68 |
Enterprise Value | — | $848.03M |
Trailing returns across standard periods
Lufax Holding Ltd is a leading financial technology (fintech) platform in China. The company operates a technology-driven personal financial services platform that offers a wide range of loans and wealth management products to its users. Lufax primarily serves the rapidly growing wealth and consumption needs of China’s mass affluent and affluent populations through a combination of its digital platform and an extensive offline network.
Read more on LU →Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →